TILRAY BRANDS INC (TLRY) Fundamental Analysis & Valuation

NASDAQ:TLRY • US88688T2096

Current stock price

6.57 USD
-0.15 (-2.23%)
At close:
6.5704 USD
+0 (+0.01%)
After Hours:

This TLRY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TLRY Profitability Analysis

1.1 Basic Checks

  • In the past year TLRY has reported negative net income.
  • TLRY had a negative operating cash flow in the past year.
  • TLRY had negative earnings in each of the past 5 years.
  • TLRY had negative operating cash flow in 4 of the past 5 years.
TLRY Yearly Net Income VS EBIT VS OCF VS FCFTLRY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B -1.5B -2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -64.81%, TLRY is doing worse than 71.35% of the companies in the same industry.
  • With a Return On Equity value of -86.34%, TLRY is not doing good in the industry: 61.98% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -64.81%
ROE -86.34%
ROIC N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
TLRY Yearly ROA, ROE, ROICTLRY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

  • TLRY has a Gross Margin of 27.68%. This is comparable to the rest of the industry: TLRY outperforms 55.73% of its industry peers.
  • TLRY's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for TLRY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
TLRY Yearly Profit, Operating, Gross MarginsTLRY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. TLRY Health Analysis

2.1 Basic Checks

  • TLRY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, TLRY has more shares outstanding
  • Compared to 5 years ago, TLRY has more shares outstanding
  • The debt/assets ratio for TLRY is higher compared to a year ago.
TLRY Yearly Shares OutstandingTLRY Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TLRY Yearly Total Debt VS Total AssetsTLRY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • Based on the Altman-Z score of -1.81, we must say that TLRY is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.81, TLRY is in line with its industry, outperforming 44.27% of the companies in the same industry.
  • A Debt/Equity ratio of 0.18 indicates that TLRY is not too dependend on debt financing.
  • TLRY has a Debt to Equity ratio (0.18) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z -1.81
ROIC/WACCN/A
WACC8.05%
TLRY Yearly LT Debt VS Equity VS FCFTLRY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.79 indicates that TLRY has no problem at all paying its short term obligations.
  • TLRY has a Current ratio of 2.79. This is comparable to the rest of the industry: TLRY outperforms 49.48% of its industry peers.
  • A Quick Ratio of 1.66 indicates that TLRY should not have too much problems paying its short term obligations.
  • The Quick ratio of TLRY (1.66) is worse than 61.46% of its industry peers.
Industry RankSector Rank
Current Ratio 2.79
Quick Ratio 1.66
TLRY Yearly Current Assets VS Current LiabilitesTLRY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TLRY Growth Analysis

3.1 Past

  • TLRY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -394.57%.
  • TLRY shows a small growth in Revenue. In the last year, the Revenue has grown by 3.82%.
  • Measured over the past years, TLRY shows a very strong growth in Revenue. The Revenue has been growing by 37.52% on average per year.
EPS 1Y (TTM)-394.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)3.82%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%11.28%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.42% on average over the next years. This is quite good.
  • Based on estimates for the next years, TLRY will show a small growth in Revenue. The Revenue will grow by 4.15% on average per year.
EPS Next Y96%
EPS Next 2Y40.7%
EPS Next 3Y25.72%
EPS Next 5Y15.42%
Revenue Next Year4.58%
Revenue Next 2Y10.6%
Revenue Next 3Y10.02%
Revenue Next 5Y4.15%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TLRY Yearly Revenue VS EstimatesTLRY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
TLRY Yearly EPS VS EstimatesTLRY Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. TLRY Valuation Analysis

4.1 Price/Earnings Ratio

  • TLRY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year TLRY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLRY Price Earnings VS Forward Price EarningsTLRY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • 79.17% of the companies in the same industry are more expensive than TLRY, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.57
TLRY Per share dataTLRY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TLRY's earnings are expected to grow with 25.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.7%
EPS Next 3Y25.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TLRY Dividend Analysis

5.1 Amount

  • TLRY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TLRY Fundamentals: All Metrics, Ratios and Statistics

TILRAY BRANDS INC

NASDAQ:TLRY (4/10/2026, 8:00:01 PM)

After market: 6.5704 +0 (+0.01%)

6.57

-0.15 (-2.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-01
Earnings (Next)07-27
Inst Owners10.43%
Inst Owner Change0%
Ins Owners0.36%
Ins Owner Change0.02%
Market Cap765.73M
Revenue(TTM)858.27M
Net Income(TTM)-1.34B
Analysts71.76
Price Target11.53 (75.49%)
Short Float %13.33%
Short Ratio5.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-84.52%
Min EPS beat(2)-100.98%
Max EPS beat(2)-68.07%
EPS beat(4)1
Avg EPS beat(4)-1358%
Min EPS beat(4)-5362.97%
Max EPS beat(4)100%
EPS beat(8)1
Avg EPS beat(8)-724.95%
EPS beat(12)2
Avg EPS beat(12)-509.78%
EPS beat(16)2
Avg EPS beat(16)-638.24%
Revenue beat(2)2
Avg Revenue beat(2)0.87%
Min Revenue beat(2)0.66%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-7.23%
Max Revenue beat(4)1.09%
Revenue beat(8)3
Avg Revenue beat(8)-4.29%
Revenue beat(12)4
Avg Revenue beat(12)-2.21%
Revenue beat(16)4
Avg Revenue beat(16)-2.83%
PT rev (1m)-0.9%
PT rev (3m)-27.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)93.34%
EPS NY rev (1m)-13.06%
EPS NY rev (3m)-15.66%
Revenue NQ rev (1m)1.33%
Revenue NQ rev (3m)-0.28%
Revenue NY rev (1m)0.8%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.98
EV/EBITDA 24.57
EPS(TTM)-13.65
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS7.36
BVpS13.36
TBVpS6.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -64.81%
ROE -86.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.68%
FCFM N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
F-Score3
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 8.12
Cap/Depr 35.43%
Cap/Sales 3.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.79
Quick Ratio 1.66
Altman-Z -1.81
F-Score3
WACC8.05%
ROIC/WACCN/A
Cap/Depr(3y)21.23%
Cap/Depr(5y)65.01%
Cap/Sales(3y)3.68%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-394.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y96%
EPS Next 2Y40.7%
EPS Next 3Y25.72%
EPS Next 5Y15.42%
Revenue 1Y (TTM)3.82%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%11.28%
Revenue Next Year4.58%
Revenue Next 2Y10.6%
Revenue Next 3Y10.02%
Revenue Next 5Y4.15%
EBIT growth 1Y54.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.37%
EBIT Next 3Y29.21%
EBIT Next 5Y17.22%
FCF growth 1Y-47.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-147.74%
OCF growth 3YN/A
OCF growth 5YN/A

TILRAY BRANDS INC / TLRY Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TILRAY BRANDS INC?

ChartMill assigns a fundamental rating of 2 / 10 to TLRY.


Can you provide the valuation status for TILRAY BRANDS INC?

ChartMill assigns a valuation rating of 1 / 10 to TILRAY BRANDS INC (TLRY). This can be considered as Overvalued.


Can you provide the profitability details for TILRAY BRANDS INC?

TILRAY BRANDS INC (TLRY) has a profitability rating of 1 / 10.


Can you provide the financial health for TLRY stock?

The financial health rating of TILRAY BRANDS INC (TLRY) is 3 / 10.